BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26311899)

  • 1. Machine Learning-based Classification of Diffuse Large B-cell Lymphoma Patients by Their Protein Expression Profiles.
    Deeb SJ; Tyanova S; Hummel M; Schmidt-Supprian M; Cox J; Mann M
    Mol Cell Proteomics; 2015 Nov; 14(11):2947-60. PubMed ID: 26311899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profiles.
    Deeb SJ; D'Souza RC; Cox J; Schmidt-Supprian M; Mann M
    Mol Cell Proteomics; 2012 May; 11(5):77-89. PubMed ID: 22442255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platform independent protein-based cell-of-origin subtyping of diffuse large B-cell lymphoma in formalin-fixed paraffin-embedded tissue.
    Reinders J; Altenbuchinger M; Limm K; Schwarzfischer P; Scheidt T; Strasser L; Richter J; Szczepanowski M; Huber CG; Klapper W; Spang R; Oefner PJ
    Sci Rep; 2020 May; 10(1):7876. PubMed ID: 32398793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-linked glycosylation enrichment for in-depth cell surface proteomics of diffuse large B-cell lymphoma subtypes.
    Deeb SJ; Cox J; Schmidt-Supprian M; Mann M
    Mol Cell Proteomics; 2014 Jan; 13(1):240-51. PubMed ID: 24190977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas.
    van der Meeren LE; Kluiver J; Rutgers B; Alsagoor Y; Kluin PM; van den Berg A; Visser L
    PLoS One; 2019; 14(10):e0223260. PubMed ID: 31603917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: results of a DASL assay.
    Kim SJ; Sohn I; Do IG; Jung SH; Ko YH; Yoo HY; Paik S; Kim WS
    Ann Hematol; 2014 Mar; 93(3):437-47. PubMed ID: 23975159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
    Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
    J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-Scale Analysis of Breast Cancer-Related Conformational Changes in Proteins Using SILAC-SPROX.
    Liu F; Meng H; Fitzgerald MC
    J Proteome Res; 2017 Sep; 16(9):3277-3286. PubMed ID: 28673085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic-Based Analysis of Hypoxia- and Physioxia-Responsive Proteins and Pathways in Diffuse Large B-Cell Lymphoma.
    Duś-Szachniewicz K; Gdesz-Birula K; Zduniak K; Wiśniewski JR
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. nCounter NanoString Assay Shows Variable Concordance With Immunohistochemistry-based Algorithms in Classifying Cases of Diffuse Large B-Cell Lymphoma According to the Cell-of-Origin.
    Saad AG; Grada Z; Bishop B; Abulsayen H; Hassan M; Firpo-Betancourt A; Teruya-Feldstein J; Fraig M; El Jamal SM
    Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):644-648. PubMed ID: 30179888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin.
    Jiang W; Zhou X; Li Z; Liu K; Wang W; Tan R; Cong X; Shan J; Zhan Y; Cui Z; Jiang L; Li Q; Shen S; Bai M; Cheng Y; Li B; Tan M; Ma DK; Liu JO; Dang Y
    Blood; 2018 Mar; 131(12):1325-1336. PubMed ID: 29437589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma.
    Romesser PB; Perlman DH; Faller DV; Costello CE; McComb ME; Denis GV
    Am J Pathol; 2009 Jul; 175(1):25-35. PubMed ID: 19498000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic evaluation of label-free and super-SILAC quantification for proteome expression analysis.
    Tebbe A; Klammer M; Sighart S; Schaab C; Daub H
    Rapid Commun Mass Spectrom; 2015 May; 29(9):795-801. PubMed ID: 26377007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers.
    Wiśniewski JR; Ostasiewicz P; Mann M
    J Proteome Res; 2011 Jul; 10(7):3040-9. PubMed ID: 21526778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma.
    Ludvigsen M; Madsen C; Kamper P; Hamilton-Dutoit SJ; Bendix K; d'Amore F; Honoré B
    Blood Cancer J; 2015 Mar; 5(3):e293. PubMed ID: 25768407
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical expression of CD10 and t(14;18) chromosomal translocation may be indicators of follicle centre cell origin in nodal diffuse large B-cell lymphoma.
    McCluggage WG; Catherwood M; Alexander HD; McBride HA; Smith ME; Morris TC
    Histopathology; 2002 Nov; 41(5):414-20. PubMed ID: 12405909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
    Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
    Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Reverse Transcriptase Multiplex Ligation-Dependent Probe Amplification Classifier: A CALYM Study.
    Bobée V; Ruminy P; Marchand V; Viailly PJ; Abdel Sater A; Veresezan L; Drieux F; Bérard C; Bohers E; Mareschal S; Dubois S; Jais JP; Leroy K; Figeac M; Picquenot JM; Molina TJ; Salles G; Haioun C; Tilly H; Jardin F
    J Mol Diagn; 2017 Nov; 19(6):892-904. PubMed ID: 29054399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches.
    Liu NQ; Dekker LJ; Stingl C; Güzel C; De Marchi T; Martens JW; Foekens JA; Luider TM; Umar A
    J Proteome Res; 2013 Oct; 12(10):4627-41. PubMed ID: 23957277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
    Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
    Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.